[Antiarrhythmic, cardiovascular and toxic effects of 4-[3'-diethylamino-2'-hydroxypropyl]-ajmaline (Tachmalcor) in comparison with ajmaline and propranolol].
D000284:Administration, Oral; D000404:Ajmaline / Q000031:analogs & derivatives / Q000494:pharmacology* / Q000633:toxicity; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats
D000889:Anti-Arrhythmia Agents; D000404:Ajmaline; D011433:Propranolol
Uber antiarrhythmische, kreislaufdynamische und toxische Wirkungen von 4-[3'-Diäthylamino-2'-hydroxypropyl]-ajmalin (Tachmalcor) im Vergleich mit Ajmalin und Propranolol